Anatomical and Functional Outcomes of Perigee and Apogee Mesh in Total Pelvic Floor Reconstruction Versus Gynecare Prolift (mesh)
Primary Purpose
Pelvic Organ Prolapse
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Perigee and Apogee Mesh
Gynecare Prolift Mesh
Traditional Surgery
Sponsored by
About this trial
This is an interventional device feasibility trial for Pelvic Organ Prolapse focused on measuring Quality of life, Vaginal mesh, Mesh complications
Eligibility Criteria
Inclusion Criteria:
- Patients with stage III ~ IV degree of anterior and posterior vaginal wall prolapse and uterine prolapse (total pelvic floor prolapse) by the Pelvic Organ Prolapse Quantification System (POP-Q) were included
Exclusion Criteria:
- Simple anterior or posterior wall prolapse, simple uterine prolapse, combined with stress urinary incontinence, overactive bladder (OAB), pelvic floor repair surgery history and recurrent patients
- Local or systemic conditions that would preclude surgery or affect healing such as restricted leg motion (inability to conform to the lithotomy position)
- Vaginal bleeding;coagulation disorders
- Infection,or uncontrolled hypertension and diabetes mellitus
- Pelvic cancer and radiation to the pelvic area in the previous 6 months.
- Also women of reproductive age, and planning of pregnancy were also excluded for mesh usage.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Placebo Comparator
Arm Label
group A
group B
group C
Arm Description
accepted Perigee and Apogee mesh(PA)
accepted Gynecare prolift mesh
Traditional surgery without any mesh
Outcomes
Primary Outcome Measures
Pelvic Organ Prolapse Quantification
the prolapse of stage II and above is defined as recurrence in POP-Q stage.
sexual quality of life through the pelvic organ prolapse / urinary incontinence sexual questionnaire
PISQ-12
pelvic floor distress inventory short form
PFDI-20
mesh exposure
mesh was seen in the vagina by gynecological examination
sexual quality of life through the pelvic organ prolapse / urinary incontinence sexual questionnaire
PISQ-12
Pelvic Organ Prolapse Quantification
the prolapse of stage II and above is defined as recurrence in POP-Q stage.
pelvic floor distress inventory short form
PFDI-20
mesh exposure
mesh was seen in the vagina by gynecological examination
sexual quality of life through the pelvic organ prolapse / urinary incontinence sexual questionnaire
PISQ-12
pelvic floor distress inventory short form
PFDI-20
Secondary Outcome Measures
stress urinary incontinence
leakage of urine with exertion or with sneezing or coughing
stress urinary incontinence
leakage of urine with exertion or with sneezing or coughing
Volume of bleeding
Elevated blood pressure
Day of postoperative indwelling catheter
Number of constipation
Full Information
NCT ID
NCT03070873
First Posted
February 15, 2017
Last Updated
February 28, 2017
Sponsor
Nanjing Medical University
1. Study Identification
Unique Protocol Identification Number
NCT03070873
Brief Title
Anatomical and Functional Outcomes of Perigee and Apogee Mesh in Total Pelvic Floor Reconstruction Versus Gynecare Prolift
Acronym
mesh
Official Title
Anatomical and Functional Outcomes of Perigee and Apogee Mesh in Total Pelvic Floor Reconstruction Versus Gynecare Prolift
Study Type
Interventional
2. Study Status
Record Verification Date
February 2017
Overall Recruitment Status
Completed
Study Start Date
January 1, 2010 (Actual)
Primary Completion Date
January 30, 2014 (Actual)
Study Completion Date
January 30, 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Nanjing Medical University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The investigators designed a prospective study in this article to evaluate the efficacy, the life quality and the complications of two different meshes of type I (one is Perigee/Apogee, the other is named Gynecare prolift) versus traditional surgery, and also studied the influence of some surgical procedures on the prognosis.
Detailed Description
Pelvic organ prolapse is defined as a downward descent of the pelvic organs that results in the protrusion of vagina, uterus, or both. The investigators designed a prospective study in this article to evaluate the efficacy, the life quality and the complications of two different meshes of type I (one is Perigee/Apogee, the other is named Gynecare prolift) versus traditional surgery. The investigators also studied the influence of some surgical procedures on the prognosis. In this study,The investigators divided the patients randomly into three groups :the group A was a total of 91 patients who accepted transvaginal hysterectomy and total pelvic floor reconstruction combined Perigee and Apogee polypropylene mesh(PA);the group B was a total of 97 patients who accepted transvaginal hysterectomy and total pelvic floor reconstruction with Gynecare prolift polypropylene mesh;the group C was a total of 70 patients who accepted transvaginal hysterectomy and anterior and posterior vaginal wall repair without any mesh.The investigators did POP-Q measurements and questionnaire preoperatively and postoperatively and recorded volume of bleeding,day of postoperative indwelling catheter and the mesh complications。
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pelvic Organ Prolapse
Keywords
Quality of life, Vaginal mesh, Mesh complications
7. Study Design
Primary Purpose
Device Feasibility
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The investigators divided the patients randomly into three groups:
The group A was a total of 91 patients who accepted transvaginal hysterectomy and total pelvic floor reconstruction combined Perigee and Apogee polypropylene mesh(PA);
The group B was a total of 97 patients who accepted transvaginal hysterectomy and total pelvic floor reconstruction with Gynecare prolift polypropylene mesh;
The group C was a total of 70 patients who accepted transvaginal hysterectomy and anterior and posterior vaginal wall repair without any mesh.
Masking
ParticipantInvestigator
Masking Description
In the study the operation was performed by three surgeons, the patients received surgery by the doctor when the patients saw in the outpatient clinic.
Allocation
Randomized
Enrollment
258 (Actual)
8. Arms, Groups, and Interventions
Arm Title
group A
Arm Type
Experimental
Arm Description
accepted Perigee and Apogee mesh(PA)
Arm Title
group B
Arm Type
Experimental
Arm Description
accepted Gynecare prolift mesh
Arm Title
group C
Arm Type
Placebo Comparator
Arm Description
Traditional surgery without any mesh
Intervention Type
Device
Intervention Name(s)
Perigee and Apogee Mesh
Intervention Description
The investigators divided the patients randomly into three groups :the group A received Perigee and Apogee polypropylene mesh(PA);the group B received Gynecare prolift polypropylene mesh;the group C was without any mesh.
Intervention Type
Device
Intervention Name(s)
Gynecare Prolift Mesh
Intervention Description
The investigators divided the patients randomly into three groups :the group A received Perigee and Apogee polypropylene mesh(PA);the group B received Gynecare prolift polypropylene mesh;the group C was without any mesh.
Intervention Type
Procedure
Intervention Name(s)
Traditional Surgery
Intervention Description
The investigators divided the patients randomly into three groups :the group A received Perigee and Apogee polypropylene mesh(PA);the group B received Gynecare prolift polypropylene mesh;the group C was without any mesh.
Primary Outcome Measure Information:
Title
Pelvic Organ Prolapse Quantification
Description
the prolapse of stage II and above is defined as recurrence in POP-Q stage.
Time Frame
at 12 months after surgery
Title
sexual quality of life through the pelvic organ prolapse / urinary incontinence sexual questionnaire
Description
PISQ-12
Time Frame
at 12 months after surgery
Title
pelvic floor distress inventory short form
Description
PFDI-20
Time Frame
at 12 months after surgery
Title
mesh exposure
Description
mesh was seen in the vagina by gynecological examination
Time Frame
at 12 months after surgery
Title
sexual quality of life through the pelvic organ prolapse / urinary incontinence sexual questionnaire
Description
PISQ-12
Time Frame
at 24 months after surgery
Title
Pelvic Organ Prolapse Quantification
Description
the prolapse of stage II and above is defined as recurrence in POP-Q stage.
Time Frame
at 24 months after surgery
Title
pelvic floor distress inventory short form
Description
PFDI-20
Time Frame
at 24 months after surgery
Title
mesh exposure
Description
mesh was seen in the vagina by gynecological examination
Time Frame
at 24 months after surgery
Title
sexual quality of life through the pelvic organ prolapse / urinary incontinence sexual questionnaire
Description
PISQ-12
Time Frame
baseline
Title
pelvic floor distress inventory short form
Description
PFDI-20
Time Frame
baseline
Secondary Outcome Measure Information:
Title
stress urinary incontinence
Description
leakage of urine with exertion or with sneezing or coughing
Time Frame
at 1 months after surgery
Title
stress urinary incontinence
Description
leakage of urine with exertion or with sneezing or coughing
Time Frame
3 months after surgery
Title
Volume of bleeding
Time Frame
during the operation
Title
Elevated blood pressure
Time Frame
during the operation
Title
Day of postoperative indwelling catheter
Time Frame
1 months after surgery
Title
Number of constipation
Time Frame
1 months after surgery
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with stage III ~ IV degree of anterior and posterior vaginal wall prolapse and uterine prolapse (total pelvic floor prolapse) by the Pelvic Organ Prolapse Quantification System (POP-Q) were included
Exclusion Criteria:
Simple anterior or posterior wall prolapse, simple uterine prolapse, combined with stress urinary incontinence, overactive bladder (OAB), pelvic floor repair surgery history and recurrent patients
Local or systemic conditions that would preclude surgery or affect healing such as restricted leg motion (inability to conform to the lithotomy position)
Vaginal bleeding;coagulation disorders
Infection,or uncontrolled hypertension and diabetes mellitus
Pelvic cancer and radiation to the pelvic area in the previous 6 months.
Also women of reproductive age, and planning of pregnancy were also excluded for mesh usage.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yu-Fei Shen
Organizational Affiliation
director of Gynecology Department , Obstetrics and Gynecology Hospital Affiliated to Nanjing Medical University
Official's Role
Study Director
12. IPD Sharing Statement
Plan to Share IPD
Yes
Learn more about this trial
Anatomical and Functional Outcomes of Perigee and Apogee Mesh in Total Pelvic Floor Reconstruction Versus Gynecare Prolift
We'll reach out to this number within 24 hrs